Fierce Healthcare May 24, 2024
Updated: May 24, 11:30 p.m. ET
Below is a roundup of payer-centric news headlines you may have missed during the month of May 2024.
Blue Cross: Patients are quitting GLP-1 drugs for weight loss early
Nearly six in 10 patients quit using GLP-1 drugs for weight loss before reaching a “clinically meaningful” health benefit, Blue Cross Blue Association said.
The insurer’s research found more than 30% of patients dropped out of treatment after four weeks, before the dosage had increased to its targeted level. Most patients did not stay on the GLP-1 track through a minimum of 12 weeks, and people aged 18 to 34 were more likely to discontinue early.
“This study underscores how much more we have to...